Halozyme Therapeutics Inc（HALO）— 同类公司组
数据截至2026-11-02 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。
Halozyme Therapeutics Inc的Closelook综合评分为73/100，在同类公司组内排名第1位（共7家）——为组内最高读数。
| 名称 | 综合 | 动量 | 质量 | 估值 | 信号 | 距52周高点 |
|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics Inc | 73 | 97 | 94 | 38 | ok | 3.8% |
| ARGX.BR Argen-X | 64 | 74 | 75 | 29 | info | 15.2% |
| ONC BeiGene, Ltd. | 64 | 83 | 64 | 30 | info | 7% |
| UCB.BR UCB SA | 64 | 72 | 71 | 44 | info | 3.5% |
| ARGX argenx NV ADR | 63 | 68 | 74 | 29 | info | 18.4% |
| REGN Regeneron Pharmaceuticals Inc | 62 | 88 | 71 | 48 | bull | 0.8% |
| RIGL Rigel Pharmaceuticals Inc | 62 | 96 | 90 | 72 | ok | 3.9% |
FAQ · from the current data · as of 2026-11-02
Quick answers
Halozyme Therapeutics Inc在Closelook覆盖范围内的同类公司有哪些？
分组首先基于共同的Closelook指数成分，其次基于行业：Argen-X (ARGX.BR)、BeiGene, Ltd. (ONC)、UCB SA (UCB.BR)、argenx NV ADR (ARGX)、Regeneron Pharmaceuticals Inc (REGN)、Rigel Pharmaceuticals Inc (RIGL)。
HALO相对同类公司的评分如何？
Halozyme Therapeutics Inc的综合评分为73/100，组内排名第1位（共7家），截至2026-11-02——为组内最高。Closelook评分为研究日记读数，不构成评级或投资建议。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- RIGL Rigel Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry